3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Anemia
1
Interventions
Darbepoetin alfa
19
Epoetin Alfa
17
ACE-011
4
Cyclosporine
3
Busulfan
3
luspatercept
2
fludarabine phosphate
2
fludarabine
2
ferric carboxymaltose
2
epoetin beta
2
continuous erythropoietin receptor activator
2
Methotrexate
2
Iron-Dextran Complex
2
Filgrastim
2
Cyclophosphamide
2
vactosertib
1
thymoglobulin
1
ruxolitinib
1
roxadustat
1
peginesatide
1
pegfilgrastim
1
niraparib
1
leridistim
1
iron isomaltoside 1000
1
hematide
1
ferric gluconate
1
eltrombopag
1
angiotensin I (1-7)
1
Therapeutics
1
Thalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Anemia
×
Iron
×
Clear all
NCT00481624
2018-03-05
Procrit
University of Louisville
Phase 2
Withdrawn